Filing
Spy
Filing
Spy
Home
About
AMRX
Amneal Pharmaceuticals Inc
Global biopharmaceutical company
CUSIP: 03168L105
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2018 Q2
3 of 3 quarters
Total Value
$45.70M
Total Shares
2.78M
Net Share Change
+2.78M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Maverick Capital
$45.70M
2.78M
0.5%
NEW
Maverick Capital
$45.70M
2.78M shares
NEW
AMRX — Amneal Pharmaceuticals Inc - FilingSpy